To the Editor: I would like to provide some background from the literature for the report by David J. Hellerstein, M.D., et al.
+(1). Although the authors’ finding appears to be solid and valid, it is not new. There is literature going back decades regarding how treatment of an axis I disorder can reduce measured personality dysfunction in both anxiety and depression
+(2–
+4). There is also literature indicating that these personality changes have clinical significance
+(5). Finally, there is also a growing literature on the effects of pharmacology on personality; an example is a review by Soloff
+(6).